531 related articles for article (PubMed ID: 1116479)
21. Plasma glucagon immunoreactivity in a totally pancreatectomized patient.
Villanueva ML; Hedo JA; Marco J
Diabetologia; 1976 Dec; 12(6):613-6. PubMed ID: 1001850
[TBL] [Abstract][Full Text] [Related]
22. Response of extrapancreatic glucagon to glycemic changes.
Ohneda A; Kobayashi T; Nihei J
Endocrinol Jpn; 1980 Dec; 27 Suppl 1():121-6. PubMed ID: 7014202
[TBL] [Abstract][Full Text] [Related]
23. Immunoreactive glucagon and insulin C-peptide in man after resection of the pancreas and total pancreatectomy.
Kåresen R; Tronier B; Aune S
Am J Surg; 1980 Aug; 140(2):272-6. PubMed ID: 6996505
[TBL] [Abstract][Full Text] [Related]
24. Heterogeneity of plasma glucagon immunoreactivity in normal, depancreatized, and alloxan-diabetic dogs.
Valverde I; Dobbs R; Unger RH
Metabolism; 1975 Sep; 24(9):1021-8. PubMed ID: 1152674
[TBL] [Abstract][Full Text] [Related]
25. Heterogeneity of plasma glucagon. Circulating components in normal subjects and patients with chronic renal failure.
Kuku SF; Jaspan JB; Emmanouel DS; Zeidler A; Katz AI; Rubenstein AH
J Clin Invest; 1976 Sep; 58(3):742-50. PubMed ID: 956399
[TBL] [Abstract][Full Text] [Related]
26. Persistence of immunoreactive insulin, glucagon and pancreatic polypeptide in the plasma of depancreatized chickens.
Colca JR; Hazelwood RL
J Endocrinol; 1982 Mar; 92(3):317-26. PubMed ID: 7040582
[TBL] [Abstract][Full Text] [Related]
27. The effect of tolbutamide and hepatic extraction of insulin and glucagon and hepatic glucose output in anesthetized dogs.
Ishida T; Chou MC; Lewis RM; Hartley CJ; Entman M; Field JB
Endocrinology; 1981 Aug; 109(2):443-50. PubMed ID: 7018888
[TBL] [Abstract][Full Text] [Related]
28. Effects of intraduodenal administration of HCl and glucose on circulating immunoreactive secretin and insulin concentrations.
Boden G; Essa N; Owen OE; Reichle FA
J Clin Invest; 1974 Apr; 53(4):1185-93. PubMed ID: 4815082
[TBL] [Abstract][Full Text] [Related]
29. The effect of somatostatin on the hepatic extraction of insulin and glucagon in the anesthetized dog.
Ishida T; Röjdmark S; Bloom G; Chou MC; Field JB
Endocrinology; 1980 Jan; 106(1):220-30. PubMed ID: 7349954
[TBL] [Abstract][Full Text] [Related]
30. Direct and indirect effects of insulin in suppressing glucose production in depancreatized dogs: role of glucagon.
Giacca A; Fisher SJ; McCall RH; Shi ZQ; Vranic M
Endocrinology; 1997 Mar; 138(3):999-1007. PubMed ID: 9048601
[TBL] [Abstract][Full Text] [Related]
31. Reciprocal gastropancreatic modulations for the release of somatostatin-like immunoreactivity, glucagon, and insulin in the rat.
Marre M; Miller J; Helman AM; Assan R
Diabetes; 1983 Aug; 32(8):768-73. PubMed ID: 6347773
[TBL] [Abstract][Full Text] [Related]
32. Extrapancreatic glucagon in control of glucose turnover in depancreatized dogs.
Ross G; Lickley L; Vranic M
Am J Physiol; 1978 Feb; 234(2):E213-19. PubMed ID: 623297
[TBL] [Abstract][Full Text] [Related]
33. Characterization of the responses of circulating glucagon-like immunoreactivity to intraduodenal and intravenous administration of glucose.
Unger RH; Ohneda A; Valverde I; Eisentraut AM; Exton J
J Clin Invest; 1968 Jan; 47(1):48-65. PubMed ID: 5638120
[TBL] [Abstract][Full Text] [Related]
34. Arginine infusion in dogs. Model for the roles of insulin and glucagon in regulating glucose turnover and free fatty acid levels.
Cherrington AD; Kawamori R; Pek S; Vranic M
Diabetes; 1974 Oct; 23(10):805-15. PubMed ID: 4422477
[No Abstract] [Full Text] [Related]
35. Effect of growth hormone on acute glucagon and insulin release.
Sirek A; Vranic M; Sirek OV; Vigas M; Policova Z
Am J Physiol; 1979 Aug; 237(2):E107-12. PubMed ID: 380363
[TBL] [Abstract][Full Text] [Related]
36. Intraportal GLP-1 infusion increases nonhepatic glucose utilization without changing pancreatic hormone levels.
Johnson KM; Edgerton DS; Rodewald T; Scott M; Farmer B; Neal D; Cherrington AD
Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E1085-91. PubMed ID: 17684104
[TBL] [Abstract][Full Text] [Related]
37. [Influence of total pancreatectomy on the secretion of human growth hormone and the endocrine pancreas].
Takaesu Y; Nimura Y; Hayakawa N; Yasui K; Ohtsuka K
Nihon Geka Gakkai Zasshi; 1988 Oct; 89(10):1686-91. PubMed ID: 3059167
[TBL] [Abstract][Full Text] [Related]
38. Effect of L-364,718 on pancreatic endocrine function following partial pancreatectomy.
Presti ME; Niehoff ML; Burton FR; Solomon H; Garvin PJ
J Surg Res; 1996 Aug; 64(2):170-5. PubMed ID: 8812629
[TBL] [Abstract][Full Text] [Related]
39. Contribution of partial pancreatectomy, systemic hormone delivery, and duct obliteration to glucose regulation in canine pancreas. Importance in pancreas transplantation.
van der Burg MP; Gooszen HG; Guicherit OR; Jansen JB; Frölich M; van Haastert FA; Lamers CB
Diabetes; 1989 Sep; 38(9):1082-9. PubMed ID: 2670640
[TBL] [Abstract][Full Text] [Related]
40. Effects of total pancreatectomy on the secretion of gut glucagon in humans.
Yasui K
Jpn J Surg; 1983 Mar; 13(2):122-9. PubMed ID: 6350663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
